We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
In cooperation with Association of Corporate Counsel
  Request new password

Search results

Order by most recent / most popular / relevance

Results: 1-10 of 40

Maximising a patentee's legal costs recovery in successful patent litigation

  • Davies Collison Cave
  • -
  • Australia
  • -
  • June 13 2014

Section 19 of the Patents Act 1990 (Cth) arises infrequently in practice, but its provisions can be of real value to a patentee, as was shown in

Pharmaceutical generic patent indirect infringement victory overturned

  • Davies Collison Cave
  • -
  • Australia
  • -
  • May 21 2014

In a unanimous decision handed down on 19 May 2014 in Warner-Lambert Co LLC v Apotex Pty Ltd 2014 FCAFC 59 (Warner-Lambert), the Full Court made it

TGA's guidance on clinical trial data and commercially confidential information

  • Davies Collison Cave
  • -
  • Australia
  • -
  • May 20 2014

The Therapeutic Goods Administration (TGA) recently undertook a review of its treatment of commercially confidential information (CCI), and published

Federal Court confirms "key-hole arrangement" patent lacks inventive step

  • Davies Collison Cave
  • -
  • Australia, Canada
  • -
  • February 24 2014

Justice Robertson of the Federal Court of Australia has recently dismissed an appeal against the Commissioner of Patent's finding that key claims of a

Australian government seeks to bolster powers under Therapeutic Goods legislation

  • Davies Collison Cave
  • -
  • Australia
  • -
  • February 13 2014

In December 2013, the Minister for Health introduced the Therapeutic Goods Amendment (2013 Measures No.1) Bill 2013 (the Bill) into Parliament. The

Chemist Warehouse web pages fall foul of TGA's advertising laws

  • Davies Collison Cave
  • -
  • Australia
  • -
  • February 6 2014

He Therapeutic Products Advertising Complaints Resolution Panel has requested that Chemist Warehouse formally retract "health information" web pages

Multisteps decision sheds further light on application of the Designs Act 2003

  • Davies Collison Cave
  • -
  • Australia
  • -
  • December 16 2013

Justice Yates has considered the "informed user" test under the Designs Act 2003 (Cth), and the role of experts, in the Federal Court case of

Generic EVISTA kept out of market pending determination of patent infringement claims

  • Davies Collison Cave
  • -
  • Australia
  • -
  • December 5 2013

The Australian Federal Court has recently made orders preventing generic pharmaceutical company, Generic Health, from promoting and selling generic

Full Federal Court agrees that copyright subsists in original printer cartridge chart

  • Davies Collison Cave
  • -
  • Australia
  • -
  • January 30 2013

In a continuation of a battle between two printer cartridge resellers, the Full Federal Court has affirmed the legal principles pronounced by the

Hospira ordered to withdraw PBS application pending determination of Novartis' Patent infringement claims

  • Davies Collison Cave
  • -
  • Australia
  • -
  • November 14 2012

The Federal Court has recently made orders restraining Hospira from promoting, supplying and obtaining PBS listing of products containing zoledronic acid until its final determination of Novartis’ allegations of patent infringement and Hospira’s cross-claims for invalidity